Pasithea Therapeutics Corp. (KTTA)
0.5801
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
0.5801
0.00 (0.00%)
After-Hours: 16:03
Pasithea Therapeutics Price to Book Value : 0.3889 for Sept. 4, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 03, 2026 | 0.3891 |
| September 02, 2026 | 0.3891 |
| September 01, 2026 | 0.3775 |
| August 31, 2026 | 0.3848 |
| August 28, 2026 | 0.3754 |
| August 27, 2026 | 0.3718 |
| August 26, 2026 | 0.3821 |
| August 25, 2026 | 0.3754 |
| August 24, 2026 | 0.3386 |
| August 21, 2026 | 0.3616 |
| August 20, 2026 | 0.3151 |
| August 19, 2026 | 0.3285 |
| August 18, 2026 | 0.3336 |
| August 17, 2026 | 0.3205 |
| August 14, 2026 | 0.3221 |
| August 13, 2026 | 0.3205 |
| August 12, 2026 | 0.3285 |
| August 11, 2026 | 0.3199 |
| August 10, 2026 | 0.3178 |
| August 07, 2026 | 0.3397 |
| August 06, 2026 | 0.2974 |
| August 05, 2026 | 0.3017 |
| August 04, 2026 | 0.3084 |
| August 03, 2026 | 0.2994 |
| July 31, 2026 | 0.3083 |
| Date | Value |
|---|---|
| July 30, 2026 | 0.2977 |
| July 29, 2026 | 0.3017 |
| July 28, 2026 | 0.3017 |
| July 27, 2026 | 0.3017 |
| July 24, 2026 | 0.305 |
| July 23, 2026 | 0.3219 |
| July 22, 2026 | 0.3084 |
| July 21, 2026 | 0.3049 |
| July 20, 2026 | 0.3173 |
| July 17, 2026 | 0.3017 |
| July 16, 2026 | 0.3065 |
| July 15, 2026 | 0.3205 |
| July 14, 2026 | 0.3231 |
| July 13, 2026 | 0.3285 |
| July 10, 2026 | 0.3301 |
| July 09, 2026 | 0.3352 |
| July 08, 2026 | 0.3429 |
| July 07, 2026 | 0.3485 |
| July 06, 2026 | 0.3486 |
| July 02, 2026 | 0.3686 |
| July 01, 2026 | 0.3801 |
| June 30, 2026 | 0.3455 |
| June 29, 2026 | 0.2394 |
| June 26, 2026 | 0.2472 |
| June 25, 2026 | 0.2464 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.690 |
| Alnylam Pharmaceuticals, Inc. | 26.28 |
| Anika Therapeutics, Inc. | 2.030 |
| Savara, Inc. | 7.671 |
| Vericel Corp. | 5.558 |
Price to Book Value Related Metrics
| Price | 0.5801 |
| Earnings Yield | -272.3% |
| Market Cap | 19.38M |